Effect of process parameters on the characteristics of porous calcium phosphate ceramics for bone tissue scaffolds

Artificial Organs

Volumn 27, Issue 5, 2003, Pages 406-411

  De Oliveira, J F ^a   De Aguiar, P F ^a   Rossi, A M ^b   Soares, Gloria De Almeida ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b CENTRO BRASILEIRO DE PESQUISAS FÍSICAS   (Brazil)

Author keywords

Calcium phosphate; Hydroxyapatite; Porosity; Scaffolds

Indexed keywords

BIOCERAMICS; BONE; CALCIUM PHOSPHATE; HYDROXYAPATITE; INFRARED SPECTROSCOPY; SCAFFOLDS (BIOLOGY); TRANSMISSION CONTROL PROTOCOL; X RAY DIFFRACTION;

BONE SUBSTITUTES; BONE TISSUE SCAFFOLDS; CALCIUM PHOSPHATE CERAMICS; MACRO-POROSITY; MICRO AND MACRO; MICRO-POROSITY; NAPHTHALENE CONTENT; POROUS HYDROXYAPATITE; PROCESS PARAMETERS; TRI-CALCIUM PHOSPHATES;

POROSITY;

CALCIUM PHOSPHATE; HYDROXYAPATITE; NAPHTHALENE;

BONE PROSTHESIS; CONFERENCE PAPER; IMAGE ANALYSIS; INFRARED SPECTROSCOPY; POROSITY; PRIORITY JOURNAL; STOICHIOMETRY; X RAY DIFFRACTION;

EID: 0038403757     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.2003.07247.x     Document Type: Conference Paper

References (16)

1. Chang BS, Lee CK, Hong KS. Osteoconduction at porous hydroxyapatite with various pore configurations. Biomaterials 2000;21:1291-8.
2. Hing KA, Best SM, Bonfield W. Characterization of porous hydroxyapatite. J Mater Sci Mater Med 1999;10:135-45.
3. Suchanek W, Yoshimura M. Processing and properties of hydroxyapatite-based biomaterials for use as hard tissue replacement implants. J Mater Res 1998;13:94-117.
4. Aoki H. Medical Applications of Hydroxyapatite, St. Louis: Ishyyaku EuroAmerica Inc., 1994.
5. Yang X, Wang Z. Synthesis of biphasic ceramics of hydroxyapatite and β - tricalcium phosphate with controlled phase content and porosity. J Mater Chem 1998;8:2233-7.
6. Baksh D, Davies JE. Design strategies for 3-dimensional bone tissue in vitro. In: Davies JE, ed. Bone Engineering, Toronto: Interrobang Cgraphic Design Inc. 2000:488-95.
7. Netz DJA, Sepulveda P, Pandolfelli VC, Spadaro ACC, Alencastre JB, Bentley MVLB, Marchetti JM. Potential use gelcasting hydroxyapatite porous ceramic as an implantable drug delivery system. Int J Pharm 2001;213:117-25.
8. Paul W, Sharma CP. Development of porous spherical hydroxyapatite granules: application towards protein delivery. J Mater Sci Mater Med 1999;10:383-8.
9. Bauer TW, Muschler GF. Bone graft materials: an overview of the basic science. Clin Orthop 2000;371:10-27.
10. Ducheyne P, Qiu Q. Bioactive ceramics: the effect of surface reactivity on bone formation and bone cell function. Biomaterials 1999;20:2287-303.
11. LeGeros RZ, LeGeros JP, Daculsi G, Kijkowska R. Calcium phosphate biomaterials: preparation, properties, and biodegradation. In: Wise DL et al., eds. Encyc Hand of Biomat and Bioeng. New York: Marcel Dekker, Inc., 1995: Part.A, Vol.2:43;1429-63.
12. Balmain N, Legros R, Bonel G. X-ray diffraction of calcined bone tissue: a reliable method for the determination of bone Ca/P molar ratio. Calcif Tissue Int 1982;34:S93-S98.
13. Raynaud S, Champion E, Bernache-Assollant D, Thomas P. Calcium phosphate apatites with variable Ca/P atomic ratio I. Synthesis, characterisation and thermal stability of powders. Biomaterials 2002;23:1065-72.
14. Vaz L, Lopes AB. Porosity control of hydroxyapatite implants. J Mater Sci Mater Med 1999;10:239-42.
15. Monteriro MM, Rocha NCC, Rossi AM, Soares GA. Dissolution properties of calcium phosphate granules with different compositions in simulated body fluid. J Biomed Mater Res (in press).
16. Boyde A, Corsi A, Quarto R, Cancedda R, Bianco P. Osteconduction in large macroporous hydroxyapatite ceramic implants: evidence for a complementary integration and disintegration mechanism. Bone 1999;6:579-89.